Ocular Therapeutix
OCUL
OCUL
72 hedge funds and large institutions have $144M invested in Ocular Therapeutix in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
10.38% less ownership
Funds ownership: 63.79% → 53.41% (-10%)
16% less capital invested
Capital invested by funds: $170M → $144M (-$26.6M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
72
Holding in Top 10
2
Calls
$1.81M
Puts
$2.02M
Top Buyers
| 1 | +$3.12M | |
| 2 | +$828K | |
| 3 | +$547K | |
| 4 |
CI
Cowen Inc
New York
|
+$456K |
| 5 |
State Street
Boston,
Massachusetts
|
+$378K |
Top Sellers
| 1 | -$11.4M | |
| 2 | -$5.1M | |
| 3 | -$4.73M | |
| 4 |
PVMCV
Polaris Venture Management Co V
Boston,
Massachusetts
|
-$3.56M |
| 5 |
Morgan Stanley
New York
|
-$1.91M |